This result paves the way for the design of dual CCR5/CXCR4 targeted peptides as novel potential anti-AIDS therapeutics, which would mimic the 13–21 HIV-1 gp120 V3 loop binding in complex with both coreceptors. Here, CXCR4 is linked to AIDS.